๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2829088 17 M TX 03/03/2025 HEP
GLAXOSMITHKLINE BIOLOGICALS
5JX2E
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
seventeen year old patient received an adult dose of Engerix-B; seventeen year old patient received ... seventeen year old patient received an adult dose of Engerix-B; seventeen year old patient received an adult dose of Engerix-B; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult product administered to child in a 18-year-old male patient who received HBV (Engerix B adult) (batch number 5JX2E, expiry date 14-DEC-2026) for prophylaxis. On 25-NOV-2024, the patient received Engerix B adult. On 25-NOV-2024, an unknown time after receiving Engerix B adult, the patient experienced adult product administered to child (Verbatim: seventeen year old patient received an adult dose of Engerix-B) and overdose (Verbatim: seventeen year old patient received an adult dose of Engerix-B). The outcome of the adult product administered to child and overdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-FEB-2025 The reporter reported that a seventeen year old patient received an adult dose of Engerix B last year, which led to adult product administered to child and overdose. The reporter added now this patient was 18 years old and asked if the patient needs to receive another dose, and wanted to know was the patient covered. More
2829089 MD 03/03/2025 HEPA
GLAXOSMITHKLINE BIOLOGICALS
Y3ME2
Expired product administered Expired product administered
Administration of expired dose; This non-serious case was reported by a pharmacist via call center r... Administration of expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix 720) (batch number Y3ME2, expiry date 25-FEB-2025) for prophylaxis. On 25-FEB-2025, the patient received Havrix 720. On 25-FEB-2025, an unknown time after receiving Havrix 720, the patient experienced expired vaccine used (Verbatim: Administration of expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-FEB-2025 The reporter reported that the patient had given expired hep A vaccine just 2 day later from the expiration day which led to expired vaccine used. The reporter had to re-vaccinated the patient or not. This adverse event was received via Webform. No further details provided. More
2829090 73 M NM 03/03/2025 DTAPIPV
GLAXOSMITHKLINE BIOLOGICALS
42Y93
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
he was supposed to received Tdap (Boostrix), unfortunately the medical assistant gave him the Dtap (... he was supposed to received Tdap (Boostrix), unfortunately the medical assistant gave him the Dtap (Kinrix); Administration to a 73 year old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 73-year-old male patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 24-FEB-2025, the patient received Kinrix. On an unknown date, the patient received Boostrix. On 24-FEB-2025, an unknown time after receiving Kinrix and Boostrix, the patient experienced wrong vaccine administered (Verbatim: he was supposed to received Tdap (Boostrix), unfortunately the medical assistant gave him the Dtap (Kinrix)) and inappropriate age at vaccine administration (Verbatim: Administration to a 73 year old patient). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-Feb-2025 There was an error yesterday with a vaccine that was administered. The patient was supposed to received Tdap (Boostrix), unfortunately the medical assistant gave him the Dtap, the reporter believe is the Kinrix which led to wrong vaccine administered and inappropriate age at vaccine administration. The reporter need to know if that was going to cause the patient any issue. The Vaccine Administration Facility is the same as Primary Reporter. More
2829091 M CA 03/03/2025 HEPAB
GLAXOSMITHKLINE BIOLOGICALS
B9279
Inappropriate schedule of product administration Inappropriate schedule of product administration
Patient received second dose of Twinrix late; This non-serious case was reported by a pharmacist via... Patient received second dose of Twinrix late; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 52-year-old male patient who received HAB (Twinrix) (batch number B9279, expiry date 12-SEP-2026) for prophylaxis. Previously administered products included Twinrix (received 1st dose of Twinrix on 6th May 2023 with batch number 2PG309 and expiry date 19th September 2025). On 09-JAN-2025, the patient received the 2nd dose of Twinrix. On 09-JAN-2025, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: Patient received second dose of Twinrix late). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-FEB-2025 The reporter wanted to know how the second dose should have been administered. The vaccine administration facility was the same as primary reporter. The patient received 2nd dose of Twinrix, later than the recommended interval, which led to lengthening of vaccinations schedule. This is 1 of 4 linked cases reported by the same reporter.; Sender's Comments: US-GSK-US2025023741:same reporter US-GSK-US2022160192:same reporter US-GSK-US2020191512:same reporter More
2829092 F CA 03/03/2025 COVID19
JANSSEN
Unknown
Disability, Hypersensitivity, Mast cell activation syndrome, Postural orthostati... Disability, Hypersensitivity, Mast cell activation syndrome, Postural orthostatic tachycardia syndrome More
Mast Cell Activation Syndrome (MCAS); became disabled; Allergic reactions to covid-19 vaccine; Postu... Mast Cell Activation Syndrome (MCAS); became disabled; Allergic reactions to covid-19 vaccine; Postural Orthostatic Tachycardia Syndrome (POTS); This spontaneous report received from a health care professional concerned a female patient of unspecified age. The patient's height and weight were not reported. Age at time of vaccination was unknown. The patient's concurrent conditions included: flu, ivf, and recurring ruptured ovarian cysts. The patient received janssen covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose and frequency not reported, administered on 2021, additional dosage information included: dose series 1, for covid-19 prophylaxis. The batch number was not reported. The company is unable to perform follow up. No concomitant medications were reported. On 2021, the patient experienced mast cell activation syndrome (mcas), became disabled, allergic reactions to covid-19 vaccine, and postural orthostatic tachycardia syndrome (pots). (dose series 1). It was reported that patient experienced: The patient had an allergic reaction to the vaccine, after the allergic reaction to the COVID vaccine the patient developed Mast Cell Activation Syndrome (MCAS), Postural Orthostatic Tachycardia Syndrome (POTS), food allergies, food sensitivities, allergic to makeup, allergic to hair dye, and became disabled. The action taken with janssen covid-19 vaccine was not applicable. The patient had not recovered from mast cell activation syndrome (mcas), became disabled, allergic reactions to covid-19 vaccine and postural orthostatic tachycardia syndrome (pots). This report was serious (other medically important condition).; Sender's Comments: V0- Mast cell activation syndrome , disability, Drug hypersensitivity, : Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable. More
2829093 M 03/03/2025 COVID19
MODERNA

Feeling drunk Feeling drunk
After second moderna covid-19 shot whenever he drinks coffee, dairy, consume red meat, he feels &quo... After second moderna covid-19 shot whenever he drinks coffee, dairy, consume red meat, he feels "drunk."; This spontaneous case was reported by a patient and describes the occurrence of FEELING DRUNK (After second moderna covid-19 shot whenever he drinks coffee, dairy, consume red meat, he feels "drunk.") in a male patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced FEELING DRUNK (After second moderna covid-19 shot whenever he drinks coffee, dairy, consume red meat, he feels "drunk."). At the time of the report, FEELING DRUNK (After second moderna covid-19 shot whenever he drinks coffee, dairy, consume red meat, he feels "drunk.") outcome was unknown. No concomitant medications were reported. Patient also felt like drunk driving. The caller wanted to ask if there was any reversal for this and any information of how often this kind of event was reported. It was unknown if the patient experienced any additional symptoms/events. No treatment medications were reported. Reporter did not allow further contact More
2829094 57 M AR 03/03/2025 COVID19
MODERNA

Apathy, Fatigue, Feeling abnormal, Illness, Influenza Apathy, Fatigue, Feeling abnormal, Illness, Influenza
Patient had absolutely lost all motivation; Patient was so sick of being sick; Tired; Patient had de... Patient had absolutely lost all motivation; Patient was so sick of being sick; Tired; Patient had described as flu which was same effect after booster but for longer; Patient laid around sick and it was utterly miserable; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA (Patient had described as flu which was same effect after booster but for longer), FEELING ABNORMAL (Patient laid around sick and it was utterly miserable), APATHY (Patient had absolutely lost all motivation), ILLNESS (Patient was so sick of being sick) and FATIGUE (Tired) in a 55-year-old male patient who received mRNA-1273 (Spikevax) for Emesis. Concurrent medical conditions included COPD and Blood pressure high. On 13-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular use) 1 dosage form. On 14-Apr-2022, the patient experienced INFLUENZA (Patient had described as flu which was same effect after booster but for longer) and FEELING ABNORMAL (Patient laid around sick and it was utterly miserable). On an unknown date, the patient experienced APATHY (Patient had absolutely lost all motivation), ILLNESS (Patient was so sick of being sick) and FATIGUE (Tired). At the time of the report, INFLUENZA (Patient had described as flu which was same effect after booster but for longer) and FEELING ABNORMAL (Patient laid around sick and it was utterly miserable) had not resolved and APATHY (Patient had absolutely lost all motivation), ILLNESS (Patient was so sick of being sick) and FATIGUE (Tired) outcome was unknown. No concomitant medication was reported. Patient was laid around sick to stomach and utterly miserable. He had absolutely lost all motivation and would do anything that bought pleasure to him. It was unknown if the patient had any additional medical history, concomitant disease or risk factor. No treatment information was reported. More
2829095 54 F WA 03/03/2025 COVID19
MODERNA

Deafness, Tinnitus Deafness, Tinnitus
moderate hearing loss; tinnitus; This spontaneous case was reported by a patient and describes the o... moderate hearing loss; tinnitus; This spontaneous case was reported by a patient and describes the occurrence of DEAFNESS (moderate hearing loss) in a 54-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced DEAFNESS (moderate hearing loss) (seriousness criterion medically significant) and TINNITUS (tinnitus). At the time of the report, DEAFNESS (moderate hearing loss) and TINNITUS (tinnitus) had not resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. For SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use), the reporter did not provide any causality assessments. No Concomitant medications provided by the reporter. It was reported that patient was developed Tinnitus and moderate hearing loss over a period of a month. No treatment medications provided by the reporter.; Reporter's Comments: Company Comments; The benefit-risk relationship of product is not affected by this report More
2829096 85 F VA 03/03/2025 COVID19
PFIZER\BIONTECH

Death, Lethargy, Malaise Death, Lethargy, Malaise
Lethargic, very unwell, death Lethargic, very unwell, death
โœ“ โœ“
2829097 4 M SC 03/03/2025 DTAPIPV
MMRV
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
5H95B
X021755
Expired product administered; Expired product administered Expired product administered; Expired product administered
MMRV (ProQuad) was given on 02/25/25 and expired on 02/23/25. MMRV (ProQuad) was given on 02/25/25 and expired on 02/23/25.
2829098 0.17 M 03/03/2025 DTPPVHBHPB
HEP
MSP VACCINE COMPANY
GLAXOSMITHKLINE BIOLOGICALS


Gastrooesophageal reflux disease, Hypotonia, Lethargy, Respiratory arrest, Seizu... Gastrooesophageal reflux disease, Hypotonia, Lethargy, Respiratory arrest, Seizure like phenomena; Gastrooesophageal reflux disease, Hypotonia, Lethargy, Respiratory arrest, Seizure like phenomena More
Same day seizure like sounds and body language. 2 days later lethargic., breathing complications. S... Same day seizure like sounds and body language. 2 days later lethargic., breathing complications. Stopped breathing and was limp.. We went to the ER and spent the night on monitors. It was ruled as acid reflux but he doesn?t have reflux due to nissen surgery which was done at 1month. I brought up how he had his 2 month shots and they said this wouldn?t be from that. More
2829099 15 F SC 03/03/2025 HPV9
MNQ
MERCK & CO. INC.
SANOFI PASTEUR
w026152
u7996ba
Expired product administered, No adverse event; Expired product administered, No... Expired product administered, No adverse event; Expired product administered, No adverse event More
HPV Vaccine expired 01/29/2025 and was given 02/27/2025. No adverse events reported as of 03/03/2025... HPV Vaccine expired 01/29/2025 and was given 02/27/2025. No adverse events reported as of 03/03/2025. Parent/guardian notified of expired dose being administered, and advised to bring child in for re-vaccination. More
2829100 53 F MI 03/03/2025 TYP
BERNA BIOTECH, LTD.
3004089
Incorrect dose administered, No adverse event Incorrect dose administered, No adverse event
Client took all 4 doses of Oral Typhoid as one dose on 2/13/25. No reported symptoms. Client took all 4 doses of Oral Typhoid as one dose on 2/13/25. No reported symptoms.
2829101 53 F CT 03/03/2025 COVID19
COVID19
COVID19
COVID19
COVID19
MODERNA
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH





Graves' disease; Graves' disease; Graves' disease; Graves' d... Graves' disease; Graves' disease; Graves' disease; Graves' disease; Graves' disease More
Diagnosed with Graves Disease. Diagnosed with Graves Disease.
2829102 15 F SC 03/03/2025 HPV9
MNQ
MERCK & CO. INC.
SANOFI PASTEUR
w026152
U8351CA
Expired product administered, No adverse event; Expired product administered, No... Expired product administered, No adverse event; Expired product administered, No adverse event More
HPV Vaccine expired 01/29/2025 and was given 02/27/2025. No adverse events reported as of 03/03/2025... HPV Vaccine expired 01/29/2025 and was given 02/27/2025. No adverse events reported as of 03/03/2025. Parent/guardian notified of expired dose being administered, and advised to bring child in for re-vaccination. More
2829103 2 F MI 03/03/2025 COVID19
PFIZER\BIONTECH
LN8272
Product preparation issue, Pyrexia Product preparation issue, Pyrexia
I administered 0.3 ml of the COVID vaccine to this patient ( concentrated dose ) I didn't know ... I administered 0.3 ml of the COVID vaccine to this patient ( concentrated dose ) I didn't know that I had to dilute it with 1.1 ml of saline. Error was reported, and patient's parent was notified via interpreter. Per patient's parent patient is doing well, and had a fever of 101.0 F the night of the event, and resolved the next day. Per parents no other adverse reactions were observed. Answered parent's questions to the best of my knowledge, no other questions at this time. More
2829104 93 M FL 03/03/2025 COVID19
PFIZER\BIONTECH
lt5636
Extra dose administered, No adverse event Extra dose administered, No adverse event
no adverse effects reported, patient got vaccine out of CDC recommended dosing schedule. Last dose w... no adverse effects reported, patient got vaccine out of CDC recommended dosing schedule. Last dose was 1/9/25, most recent dose was 3/2/25. More
2829105 0.5 M MI 03/03/2025 COVID19
DTPPVHBHPB
FLU3
PNC20
RV5
PFIZER\BIONTECH
MSP VACCINE COMPANY
SANOFI PASTEUR
PFIZER\WYETH
MERCK & CO. INC.
LN8272
U8265AA
U8523DA

Y011797
Altered state of consciousness, Infantile diarrhoea, Infantile vomiting, Pyrexia... Altered state of consciousness, Infantile diarrhoea, Infantile vomiting, Pyrexia; Altered state of consciousness, Infantile diarrhoea, Infantile vomiting, Pyrexia; Altered state of consciousness, Infantile diarrhoea, Infantile vomiting, Pyrexia; Altered state of consciousness, Infantile diarrhoea, Infantile vomiting, Pyrexia; Altered state of consciousness, Infantile diarrhoea, Infantile vomiting, Pyrexia More
Altered level of consciousness 4 months after receiving Vaxelis, prevnar, rotateq, COVID and flu. So... Altered level of consciousness 4 months after receiving Vaxelis, prevnar, rotateq, COVID and flu. Some vomiting, Diarrhea and fever. Patient did go to ER when these symptoms occurred in the early afternoon. More
2829106 57 F TN 03/03/2025 COVID19
PFIZER\BIONTECH
EW0153
Asthenia, Exercise tolerance decreased, Gait disturbance, SARS-CoV-2 antibody te... Asthenia, Exercise tolerance decreased, Gait disturbance, SARS-CoV-2 antibody test More
Day of shot - I was very weak and could barely walk. This lasted for +/- 36 hours. Have felt weak ... Day of shot - I was very weak and could barely walk. This lasted for +/- 36 hours. Have felt weak ever since. Ability to exercise, decreased over time. I was taking 5 classes a week and that decreased to a handful a times per year. More
2829107 1 M NJ 03/03/2025 HEPA
MMRV
VARCEL
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
MERCK & CO. INC.



Extra dose administered, Wrong product administered; Extra dose administered, Wr... Extra dose administered, Wrong product administered; Extra dose administered, Wrong product administered; Extra dose administered, Wrong product administered More
Proquad was given instead of MMR so patient received an extra dose of varicella. Proquad was given instead of MMR so patient received an extra dose of varicella.
2829108 57 F MN 03/03/2025 MMR
MERCK & CO. INC.
Y007613
Antibody test positive, Contraindication to vaccination, Immunodeficiency Antibody test positive, Contraindication to vaccination, Immunodeficiency
Patient was given MMR vaccine while on Skyrizi and therefore immunocompromised. Patient was given MMR vaccine while on Skyrizi and therefore immunocompromised.
2829109 74 M FL 03/03/2025 PNC20
PFIZER\WYETH
lk6650
Extra dose administered Extra dose administered
duplicate vaccine 3 years apart. duplicate vaccine 3 years apart.
2829110 60 F MN 03/03/2025 TDAP
TDAP
TDAP
TDAP
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
L5229
L5229
L5229
L5229
Mobility decreased; Discomfort, Mobility decreased, Musculoskeletal discomfort, ... Mobility decreased; Discomfort, Mobility decreased, Musculoskeletal discomfort, Musculoskeletal stiffness, Pain in extremity; Mobility decreased; Discomfort, Mobility decreased, Musculoskeletal discomfort, Musculoskeletal stiffness, Pain in extremity More
Patient said her ROM was limited. 2/25/25 she took generic Aleve and on 2/27/25 she took a generic ... Patient said her ROM was limited. 2/25/25 she took generic Aleve and on 2/27/25 she took a generic Aleve. The ROM is getting better but not 100%. Wanted the report completed and to ask how long she should have symptoms? More
2829111 4 F WV 03/03/2025 DTAPIPV
GLAXOSMITHKLINE BIOLOGICALS
5G23D
Erythema, Rash, Skin warm Erythema, Rash, Skin warm
Area of erythema @ 6" laterally @ longest area of redness. 3.5" X 4". Area also had r... Area of erythema @ 6" laterally @ longest area of redness. 3.5" X 4". Area also had rash noted and was warm to the touch More
2829112 3 F VA 03/03/2025 COVID19
PFIZER\BIONTECH
Lt7427
Expired product administered, No adverse event Expired product administered, No adverse event
Patient was scheduled vaccine. The vaccine (COVID 6 months- 4 years) was reconstituted on 2/21/25. V... Patient was scheduled vaccine. The vaccine (COVID 6 months- 4 years) was reconstituted on 2/21/25. Vaccine was still in the refrigerator and administered on 2/24/25 to patient's right thigh. I realized the vaccine should have been discarded on 2/22/25, end of the day, but was not. The last dose in the reconstituted vial was administered to patient. The physician was informed of the incident. No adverse reactions noted during or after the administration of the vaccine. Pfizer was contacted. Pfizer replied they do not have supporting stability data. No additional dose was administered to patient after event. More
2829113 58 F CA 03/03/2025 HEPA
MERCK & CO. INC.
y017625
Asthenia, Chills, Constipation, Headache Asthenia, Chills, Constipation, Headache
After receiving the Hep A vaccine on the afternoon of Wednesday 2/26/25, I got a headache 3 days l... After receiving the Hep A vaccine on the afternoon of Wednesday 2/26/25, I got a headache 3 days later, on the afternoon of 3/1/25. I was very low energy all day on 3/2/25. This morning, 3/3, I woke up uncomfortably constipated. I am feeling weak and I have chills. As the day progresses, I am starting to feel better. More
2829114 84 M NY 03/03/2025 UNK
VARZOS
UNKNOWN MANUFACTURER
GLAXOSMITHKLINE BIOLOGICALS


Seizure; Seizure Seizure; Seizure
12 hrs after a single dose shingles vaccine he has a seizure event 12 hrs after a single dose shingles vaccine he has a seizure event
2829115 41 F MI 03/03/2025 MMR
MERCK & CO. INC.
Y011484
Induration, Limb mass, Pain in extremity, Skin warm Induration, Limb mass, Pain in extremity, Skin warm
She developed a hot, firm, painful mass in her left upper arm, in the location of the vaccine, but 2... She developed a hot, firm, painful mass in her left upper arm, in the location of the vaccine, but 2 weeks AFTER the vaccine. More
2829116 72 F AZ 03/03/2025 COVID19
MODERNA

COVID-19, Chills, Decreased appetite, Myalgia, Pyrexia COVID-19, Chills, Decreased appetite, Myalgia, Pyrexia
Patient did report that a few years ago she had come down with an infection of COVID and as a result... Patient did report that a few years ago she had come down with an infection of COVID and as a result held her dose of Humira for some time. She thinks she got Covid in December of 2022 but was not too sure about that. She stated at the time she was vaccinated with the first three doses of Moderna Covid vaccine (two doses in the series for the initial vaccination and a "booster" injection after that. She reported that she no longer gets the COVID vaccines because with all three vaccines she had muscle pains, chills, loss of appetite, and mild fever that lasted about 2 weeks. She reports that all issues have since resolved, however. More
2829117 20 F FL 03/03/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
JANSSEN
JANSSEN
JANSSEN
JANSSEN
JANSSEN
JANSSEN
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
1802068
1802068
1802068
1802068
1802068
1802068
FD0809
FD0809
FD0809
FD0809
FD0809
FD0809
Anosmia, Antibody test positive, Bedridden, COVID-19, Chest X-ray; Chest pain, C... Anosmia, Antibody test positive, Bedridden, COVID-19, Chest X-ray; Chest pain, Computerised tomogram, Dyspnoea, Echocardiogram, Exercise tolerance decreased; Fatigue, Fibrin D dimer increased, Gastrointestinal tube insertion, General physical health deterioration, Hyperacusis; Hyperaesthesia, Impaired work ability, Laboratory test, Magnetic resonance imaging, Malaise; Myalgia, Photophobia, Postural orthostatic tachycardia syndrome, Respiratory tract congestion, Viral infection; Weight decreased, Wheelchair user; Anosmia, Antibody test positive, Bedridden, COVID-19, Chest X-ray; Chest pain, Computerised tomogram, Dyspnoea, Echocardiogram, Exercise tolerance decreased; Fatigue, Fibrin D dimer increased, Gastrointestinal tube insertion, General physical health deterioration, Hyperacusis; Hyperaesthesia, Impaired work ability, Laboratory test, Magnetic resonance imaging, Malaise; Myalgia, Photophobia, Postural orthostatic tachycardia syndrome, Respiratory tract congestion, Viral infection; Weight decreased, Wheelchair user More
A previously healthy 24-year-old female with no significant medical history received the Janssen COV... A previously healthy 24-year-old female with no significant medical history received the Janssen COVID-19 vaccine on March 10, 2021. In October 2021, she contracted COVID-19, experiencing fatigue, congestion, and loss of smell, which has not returned. After recovering, she resumed physical activity, which triggered a relapse of symptoms with increased fatigue. She then received the Pfizer COVID-19 booster on January 22, 2022. Over the following months, she developed persistent fatigue, shortness of breath, chest pain, and post-exertional malaise. In mid-2022, she was diagnosed with POTS after participating in a Long COVID study. By early 2023, her condition worsened significantly, leading to chronic fatigue, muscle pain, and exercise intolerance, requiring extended leave from work. In December 2023, she left her job due to severe fatigue and mobility issues, later requiring a wheelchair. In July 2024, after a viral illness, her health rapidly declined, with significant weight loss, extreme fatigue, and severe hypersensitivity to light, noise, and touch. She was hospitalized, where workup showed an elevated D-Dimer but no other significant findings. Due to extreme fatigue and an inability to meet caloric needs, a feeding tube was placed. By September 2024, she lost the ability to move on her own and became fully bedbound, requiring 24/7 care. She was readmitted in December 2024, but extensive testing (MRI, CT scan, chest X-ray, ECHO, and labs) was inconclusive aside from continued elevation of D-Dimer. No further treatment was offered. Before discharge, a spike protein test was drawn and later found to be extremely elevated. Since February 12, 2025, she has been on a spike protein detox protocol, but her condition remains severe, with no significant improvement yet. She continues to experience extreme sensitivities to light, noise, and touch, remains fully bedbound, and requires 24/7 care. Despite her critical condition, insurance has denied nursing care, categorizing her case as "respite" rather than medical necessity. This has placed a severe burden on her father, who is her primary caregiver while also trying to maintain his job. The family has struggled to secure adequate care, resorting to hiring a nurse, but consistent, professional medical support remains a major challenge. She will need intensive rehabilitation, including physical and occupational therapy, to regain mobility. Given the timeline of symptoms and deterioration following vaccination and booster administration, this case represents a severe post-vaccine injury with possible long COVID overlap. More
โœ“ โœ“ โœ“
2829118 23 M AZ 03/03/2025 VARCEL
MERCK & CO. INC.
Y005920
Hypersensitivity, Throat tightness, Urticaria Hypersensitivity, Throat tightness, Urticaria
started having allergic reaction approx. 5 min after receiving vaccine. presented with hives on ba... started having allergic reaction approx. 5 min after receiving vaccine. presented with hives on back, chest, face and legs. stated that his throat seems a little tight. Fire department was called and they treated received Benadryl, Solu-Medrol, and Epi IM. was transported to ER for evaluation. More
2829119 11 M VA 03/03/2025 HPV9
MNQ
TDAP
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
Y012865
X7R4Z
X449Y
Swelling face; Swelling face; Swelling face Swelling face; Swelling face; Swelling face
ISOLATED FACIA SWELLING ISOLATED FACIA SWELLING
2829120 27 F OH 03/03/2025 HEP
MERCK & CO. INC.
T5D73
Urticaria Urticaria
Following morning pt reported waking up with hives on chest that started as mild. Two days after the... Following morning pt reported waking up with hives on chest that started as mild. Two days after the injection pt reported hives worsening and spreading to chest, stomach, and arms. Pt. took zyrtec with little relief. Pt encouraged to return to facility for treatment. Pt has not returned. Pt told to seek immediate medical attention if hives spread to facial area, difficulty breathing/SOB, or if tongue feels heavy swollen. More
2829121 70 M NY 03/03/2025 COVID19
MODERNA
033p21a
Biopsy prostate, Condition aggravated, Magnetic resonance imaging, Prostate canc... Biopsy prostate, Condition aggravated, Magnetic resonance imaging, Prostate cancer, Prostatic specific antigen increased More
After five years of minimal cancer of prostate and normal psa results, within a few weeks of covid b... After five years of minimal cancer of prostate and normal psa results, within a few weeks of covid booster, my psa started climbing rapidly. Within a couple of months I was re-diagnosed with aggressive prostate cancer. More
โœ“
2829122 59 F TX 03/03/2025 COVID19
VARZOS
PFIZER\BIONTECH
GLAXOSMITHKLINE BIOLOGICALS
LM2219
A5T73
Product storage error; Product storage error Product storage error; Product storage error
The Comirnaty COVID-19 vaccine administered to the patient had previously been subject to a temperat... The Comirnaty COVID-19 vaccine administered to the patient had previously been subject to a temperature excursion in January 2025, when a different pharmacist in charge (PIC) was overseeing operations. The vial was removed from refrigeration and left at room temperature for one to two days due to its upcoming expiration date of March 29, 2025. It was later returned to refrigeration for potential return but was administered to a patient on March 3, 2025. Patient also received Shingrix along with Comirnaty. More
2829123 75 F TN 03/03/2025 VARZOS
VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
52F7M
52F7M
52F7M
Antinuclear antibody, Blood creatine phosphokinase, Blood iron, Blood magnesium,... Antinuclear antibody, Blood creatine phosphokinase, Blood iron, Blood magnesium, C-reactive protein; Differential white blood cell count, Full blood count, Myalgia, Red blood cell sedimentation rate, Serum ferritin; Vitamin B12 More
Muscle pain, over-the-counter anti-inflammatory medications like ibuprofen occasionally, Try the mus... Muscle pain, over-the-counter anti-inflammatory medications like ibuprofen occasionally, Try the muscle and nerve support supplement samples provided to assess their benefit, physical therapy, offered referral to ortho. More
2829124 11 F ME 03/03/2025 COVID19
PFIZER\BIONTECH
LN0591
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Patient did not have an adverse effect- was just given the wrong covid vaccine. Needed 5-11 covid, w... Patient did not have an adverse effect- was just given the wrong covid vaccine. Needed 5-11 covid, was given 12+ More
2829126 66 F NJ 03/03/2025 COVID19
PFIZER\BIONTECH
EP7533
Sjogren's syndrome Sjogren's syndrome
Generalized autoimmune inflammation exacerbation of Sjogrens Syndrome Generalized autoimmune inflammation exacerbation of Sjogrens Syndrome
โœ“
2829127 63 M FL 03/03/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS
52z52
No adverse event No adverse event
Patient experienced no side effects but was given the Arexvy vaccine twice. The patient had already ... Patient experienced no side effects but was given the Arexvy vaccine twice. The patient had already gotten the vaccine in November 2023 which is not in accordance with current vaccine guidelines. More
2829128 75 F AZ 03/03/2025 PNC20
PFIZER\WYETH
LK6650
Erythema, Mobility decreased, Peripheral swelling, Skin warm Erythema, Mobility decreased, Peripheral swelling, Skin warm
Patient stated that the day after receiving Prevnar 20 her arm was swollen form her elbow to her sho... Patient stated that the day after receiving Prevnar 20 her arm was swollen form her elbow to her shoulder. She stated that it was warm to the touch, red and she could not lift it. More
2829129 0.5 F MN 03/03/2025 COVID19
PFIZER\BIONTECH
LN7302
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Patient received a Covid vaccine for age range of 5 year- 11-year-old instead of the 6m-4-year conce... Patient received a Covid vaccine for age range of 5 year- 11-year-old instead of the 6m-4-year concentration. The vaccine was diluted with 1.1 mL of 0.9% Sodium Chloride prior to injection. After discussing with manufacturer, it was determined that the correct dose was given based on the calculations. The vial contains 15.8 mg MRNA in 0.48 mL of liquid and was mixed with 1.1 mL of diluent, containing 3 mcg of MRNA in the 0.3 mL dose given to patient. Patient's family did not report any initial reactions. More
2829130 11 F MA 03/03/2025 HPV9
MNQ
TDAP
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
SANOFI PASTEUR
y010656
x7r4z
3ca30c1
Asthenia, Headache, Pain, Pain in extremity; Asthenia, Headache, Pain, Pain in e... Asthenia, Headache, Pain, Pain in extremity; Asthenia, Headache, Pain, Pain in extremity; Asthenia, Headache, Pain, Pain in extremity More
mom called office 2/24/2025 that pt on the night of2/21 was complaining of body aches and leg pain, ... mom called office 2/24/2025 that pt on the night of2/21 was complaining of body aches and leg pain, pt is middle of the night woke up complaining of headache. mom did covid test was negative states the pt was very weak for a few days and feels it is vaccine related More
2829131 62 F TX 03/03/2025 PNC20
PFIZER\WYETH

Injection site erythema Injection site erythema
round redness around the injection site. was swollen a bit but is going down overtime. round redness around the injection site. was swollen a bit but is going down overtime.
2829132 12 F TN 03/03/2025 MNQ
TDAP
NOVARTIS VACCINES AND DIAGNOSTICS
SANOFI PASTEUR
E4A39
3CA22C1
Rash, Rash pruritic; Rash, Rash pruritic Rash, Rash pruritic; Rash, Rash pruritic
6 days post vaccine administration (2/20/25) patient developed itchy rash on extremities including h... 6 days post vaccine administration (2/20/25) patient developed itchy rash on extremities including hands and feet. Trunk was clear of rash. Remained afebrile during this time. Itching controlled with cortisone OTC cream. S/S resolved 2/24/25. Parent spoke with PCP no visit. She advised that PCP suggested not receiving another dose of meningococcal vaccine. Sibling received vaccines on same date with the exception of meningococcal vaccine with no ill effects. More
2829133 4 M VA 03/03/2025 MMRV
MERCK & CO. INC.
Y009347
Product preparation issue Product preparation issue
Patient in clinic for 4 year wellness appt. Patient had Proquad and Quadracel vaccines ordered to be... Patient in clinic for 4 year wellness appt. Patient had Proquad and Quadracel vaccines ordered to be given. After vaccines given the nurse found vaccines were reconstituted incorrectly. Proquad vaccine was diluted with Quadracel vaccine and administered. Sterile Diluent was administered by itself to patient. Quadracel vaccine in clinic depending on stock (Private vs VFC) can be in pre-drawn syringe or vial. The pre-drawn syringe looks similar to sterile diluent that is to be used with Proquad reconstitution. Mother was with patient for visit and was informed by CTL that this error had occurred and RN would be in touch with her regarding if vaccinations needed to be repeated, what signs/symptoms to look for, etc. Mother voiced understanding. Child had no signs/symptoms of local reaction after vaccination. Waited in office 15 minutes. RN reached out to VFC coordinator to inquire about error and information regarding repeating. She reached out to the CDC help desk and per CDC both vaccinations will need to be repeated. The Proquad will need to wait to be repeated in 28 days. RN called and spoke with mother regarding this and explained the reasoning behind re-vaccination and a letter was written in regards to the error as mother was needing vaccinations for child to start preschool. Vaccine only appointment made for 28 days out for repeat vaccinations. Mother to call back before then with any further questions or concerns. Education was done with the nurse that administered and a new work flow for preparation of these vaccines was discussed to prevent this error in the future. More
2829134 24 F MO 03/03/2025 IPV
SANOFI PASTEUR
X1C891M
Extra dose administered, Tuberculin test Extra dose administered, Tuberculin test
Polio was inadvertently given to the patient instead of a PPD skin test. When the error was noticed... Polio was inadvertently given to the patient instead of a PPD skin test. When the error was noticed, the patient was immediately contacted and asked to return to the clinic. Patient was given the TB Skin test . The patient was informed the polio was given in error. The Health Center Manager was notified. Nurse manager followed up with the CDC. Spoke with customer service agent. Polio considered an extra dose. Nurse manager f/u with the patient to inform her of the error. Pt was understanding. More
2829135 72 M IN 03/03/2025 VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS


Chills, Headache, Hyperhidrosis, Influenza like illness, Nausea; Pain, Pain in e... Chills, Headache, Hyperhidrosis, Influenza like illness, Nausea; Pain, Pain in extremity, Pyrexia More
The patient shopped in store for 15-20 minutes and then a 20 minute drive home. Approximately 3 to ... The patient shopped in store for 15-20 minutes and then a 20 minute drive home. Approximately 3 to 4 hours after administration patient developed the following: nausea, headache, arm pain, flu-like symptoms, everything in body hurt, body aches, feverish, chills, and sweating. The patient took an Aspirin and went to bed early. The patient did not have any reaction to the 1st dose. More
2829136 29 F NY 03/03/2025 VARCEL
MERCK & CO. INC.
y014182
Asthenia, Headache, Injection site erythema, Injection site swelling Asthenia, Headache, Injection site erythema, Injection site swelling
Day of vaccine pt experienced headache and weakness. Over the weekend noticed redness and swelling t... Day of vaccine pt experienced headache and weakness. Over the weekend noticed redness and swelling to injection site. More
2829137 86 F FL 03/03/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS

Extra dose administered Extra dose administered
administration errors, was given a second dose. first was in 2023 administration errors, was given a second dose. first was in 2023
2829138 0.5 M VA 03/03/2025 UNK
UNKNOWN MANUFACTURER

Product preparation issue Product preparation issue
The dilute was given for Hiberix without the vaccination being mixed in. The Lot number for the Hib... The dilute was given for Hiberix without the vaccination being mixed in. The Lot number for the Hiberix was 5JF75 EXP 7/14/2026. More